FRAGIL-IT: Seamless Follow up and Support System for Frail Elderly Living at Home

Sponsor
University Hospital, Toulouse (Other)
Overall Status
Completed
CT.gov ID
NCT03468647
Collaborator
(none)
40
1
1
26.5
1.5

Study Details

Study Description

Brief Summary

The object of the present project is to promote the prevention of disability by providing 1) a feedback and motivational coaching to the user, 2) relevant clinical parameters to the healthcare professionals in order to support the patient's follow-up, and 3) supporting the detection of preliminary signs of functional loss. The technical solution will contain wearable (e.g. smart insole) and ambient unobtrusive devices (e.g. weigh scale including balance analysis), and analysis and diagnosis assistance software. The devices transmit wirelessly the collected data to a remote server through a tablet. Data will then be available remotely for consultations by users (i.e. patients or physicians). The clinical evaluation will be a multi-phased design with a first living lab evaluation followed by a real life home trial to finalize the evaluation. Comprehensive assessments will be conducted to highlight the feasibility and acceptability.

Condition or Disease Intervention/Treatment Phase
  • Other: soles
  • Other: weighting machine
  • Other: gripping force
N/A

Detailed Description

Functional decline challenges the sustainability of healthcare systems. There are difficulties in implementing effective interventions to prevent disability, to promote adherence to lifestyle recommendations and to perform seamless follow-up at home. A technological solution addressing this challenge and improving individual participation would be welcome. Our aim is to evaluate an instrument for supporting physical activity and monitoring multiple parameters of frailty (a pre-disability condition) in frail elderly persons. The investigator and collaborator are therefore developing a solution to monitor key parameters of frailty during subject daily life and to promote walking. This tools are :

  1. connected soles to evaluate different parameters of the volunteer walking

  2. connected weighing machine to evaluate the volunteer weight and equilibrate

  3. machine to measure gripping force because gripping force is correlated to physical condition.

The primary aim is to assess the acceptability of the solution for the follow up and the motivational coaching of frail patients at home. Results from this study will also be used to elaborate the design of a further larger national multicenter randomized control trial assessing the efficiency of the solution to prevent disability.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
FRAGIL-IT, Seamless Follow up and Support System for Frail Elderly Living at Home
Actual Study Start Date :
Oct 16, 2017
Actual Primary Completion Date :
Dec 31, 2018
Actual Study Completion Date :
Dec 31, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: FRAGIL-IT testing group

FRAGIL-IT tools : connected soles, connected weighting machine and measure of gripping force

Other: soles
Volunteer must walk this this connected seamless to measure different walking parameters
Other Names:
  • connected soles
  • Other: weighting machine
    This weighting machine measure weight evolution and equilibrate of volunteers
    Other Names:
  • connected weighting machine
  • Other: gripping force
    this machine measure the gripping force of volunteer
    Other Names:
  • gripping force machine
  • Outcome Measures

    Primary Outcome Measures

    1. acceptability of FRAGIL-IT tools [3 months]

      primary outcome is based on the acceptability of the FRAGIL-IT tools for the end-user : connected soles, connected weighting machine and measure of gripping force to control autonomy loss. The acceptability of this tools will be evaluate by questionnaire as The Short Form (36) Health Survey (SF36) questionnaire

    Secondary Outcome Measures

    1. evaluation of life quality with SF36 questionnaire [3 months]

      the life quality will be assess with SF36 questionnaire

    2. functional status measure by ADL [3 months]

      functional status will be assess with Activity of Daily Living (ADL) score. The scale of ADL is between 0 to 6. 0 is worse than 6.

    3. functional status measure by iADL [3 months]

      functional status will be assess with instrumental Activity of Daily Living (iADL) score. The scale of IADL is between 0 to 8. 0 is worse than 8.

    4. cognitive status [3 months]

      cognitive status will be assess with Mini Mental State (MMS)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patient living at home;

    • pre-frail or frail volunteers;

    • Informed and written consent by the patient or the legal representative or the reliable person when appropriate.

    Exclusion Criteria:
    • patient's life expectancy less than 12 months; patient presenting disability with an Activity of Daily Living score < 4/6 ant/or a Mini - Mental State <20/30, not walking or walking with a technical support;

    • Non agreement of study participation of patients or legal representative or the reliable person when appropriate.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Hospital, Toulouse Toulouse Midi-Pyrenes France 31059

    Sponsors and Collaborators

    • University Hospital, Toulouse

    Investigators

    • Principal Investigator: Antoine PIAU, MD, University Hospital, Toulouse

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Toulouse
    ClinicalTrials.gov Identifier:
    NCT03468647
    Other Study ID Numbers:
    • RC31/15/0603
    First Posted:
    Mar 16, 2018
    Last Update Posted:
    Nov 9, 2020
    Last Verified:
    Nov 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Toulouse

    Study Results

    No Results Posted as of Nov 9, 2020